|
Home | Medical-Newswire.Com:
|
(Medical-NewsWire.com, March 22, 2018 ) BCG vaccine stands for Bacillus Calmette-Gurin (BCG) vaccine. It prevents TB and is the only vaccine in the market which could do that. A single dose is given to an infant soon after birth in countries with high occurrence of TB. In countries which TB is not a common occurrence only high risk infants are treated with it. Adults are only treated with this vaccine if their exposure to drug-resistant TB is a regular occurrence.
Increasing number of cases of TB all over the world particularly in the developing countries of APAC, rapid advancements in technology in the field of medical research on vaccines, and savoury government policies and initiatives with improved funding are driving the growth of this market.
Explore More Information about report @ https://www.marketdataforecast.com/market-reports/global-bcg-vaccine-market-5199/
Adverse side-effects of this vaccine and supply bottlenecks all around the world are expected to hinder market growth in the forecast period.
The market segmentation is very broad and is only classified by demographics into Paediatrics (0-18 years), and Adults (19-35 years). Paediatrics is a clear market leader accounting for more than three quarters of market share and is likely to gain even more in the forecast period. It is because BCG vaccination has become mandatory in most of the countries as part of the national immunization program. Moreover, the efficacy of the vaccine is reduced if it is not administered in infancy. The usage of this vaccine is highest in Kenya. Polio and hepatitis B vaccines are usually administered alongside it.
Classification by geography entails North America, Latin America, Europe, Asia Pacific and Middle East and Africa. North America accounted for the largest market share while Asia Pacific is expected to grow with the highest CAGR due to TB eradication campaigns going on in the developing countries.
Key players in the market include Merck & Co., Inc., Sanofi Pasteur, Japan BCG Laboratory. Other players in the market include China National Biotec Group (a subsidiary of China National Pharmaceutical Group Corporation), Serum Institute of India Pvt. Ltd., InterVax Ltd., GreenSignal Bio Pharma Limited (GSBPL), and Statens Serum Institute.
Request free sample @ https://www.marketdataforecast.com/market-reports/global-bcg-vaccine-market-5199/request-sample
About Us:
Market Data Forecast is a firm working in the area of market research and business intelligence. With rich experience in research across various business domains, we cater to the needs of both individual and corporate clients. Our analyst team comprises expert professionals in market research, who with their collective knowledge and skillsets dedicatedly serve clients from various industries and regions.
Contact:
Abhishek Shukla
Sales Manager (International Business Development)
Market Data Forecast
Direct Line: +1-888-702-9626
Mobile: +91 998 555 0206
Mail: abhishek@marketdataforecast.com
Visit Market Data Forecast Blog @ http://www.marketdataforecast.com/blog/
View latest Press Releases of MDF @ http://www.marketdataforecast.com/press-releases
Market Data Forecast.
Abhishek Shukla
+1-888-702-9626
abhishek@marketdataforecast.com
Source: EmailWire.Com 
Source: EmailWire.com
|
|
|
|
